Name: 글로벌 시장 동향
SKU: MD7244
Availability: InStock

보고서 요약(국문)

개요
글로벌 디지털 흡입기 시장은 2022년 YY억 달러에 달했으며, 2023년부터 2030년까지 연평균 성장률(CAGR) YY%로 성장하여 2030년에는 YY백만 달러에 이를 것으로 예상됩니다.
디지털 흡입기는 환자의 건강 상태를 매일 확인할 수 있도록 전자 기기와 연동되는 호흡기 보조 장치입니다. 특히 천식이나 폐쇄성 폐질환과 같은 호흡기 질환 환자에게 유용합니다. 이 흡입기에 내장된 센서는 사용자가 매일 적절한 시간에 약을 복용하도록 알려줍니다.
디지털 흡입기 건강 시스템은 전기 기계식 센서와 마이크로 전자 장치를 사용하여 흡입기 작동을 모니터링합니다. 일부 기기에는 연결된 스마트폰, 환자와 소통하는 모바일 앱, 클라우드 서버, 그리고 의사가 대시보드 데이터를 확인할 수 있는 포털이 포함됩니다.
일부 디지털 흡입기는 대기 오염이나 꽃가루 농도를 측정하거나, 환자가 흡입을 잊었을 경우 알람을 울릴 수 있습니다. 스마트 흡입기는 환자가 흡입을 놓치거나 반복해서 흡입했을 때 알려주고, 정해진 시간에 자동으로 간편하게 흡입할 수 있도록 도와줍니다. 시장 동향: 성장 동인 및 제약 요인
호흡기 질환 유병률 증가
호흡기 질환 유병률 증가는 예측 기간 동안 시장 성장을 견인하는 주요 동인 중 하나입니다. 천식 및 만성 폐쇄성 폐질환(COPD)과 같은 호흡기 질환의 증가로 디지털 흡입기 사용이 급증하고 있으며, 이는 시장 성장을 촉진할 것으로 예상됩니다.
예를 들어, 미국 질병통제예방센터(CDC)에 따르면 COPD는 전 세계적으로 약 2억 명에게 영향을 미치고 있으며, 매년 320만 명이 사망하여 세계 사망 원인 3위를 차지하고 있습니다.
천식은 가장 흔한 비전염성 질환 중 하나로 전 세계 2억 6,200만 명에게 영향을 미칩니다. 2022년에는 약 220만 건의 새로운 폐암 발병 사례와 180만 명의 사망자가 발생할 것으로 예상되며, 폐암은 전 세계 암 사망의 4분의 1을 차지합니다. 하부 호흡기 감염 또는 폐렴은 매년 240만 명 이상의 사망자를 발생시키는 주요 사망 원인이며, 특히 저소득 및 중소득 국가(LMICs)에서 많이 발생합니다. 코로나19는 전 세계적으로 폐렴 사망자 수를 크게 증가시켰습니다.
또한, 흡입기 기술의 발전, 데이터 기반 의료, 고령 인구 증가, 원격 의료의 확산 등이 예측 기간 동안 시장 성장을 견인할 것으로 예상됩니다.
시장 동향: 제약 요인
예측 기간 동안 시장 성장을 저해하는 여러 제약 요인이 있습니다. 주요 제약 요인으로는 약물 비용 증가, 기기 관련 높은 가격, 개인정보 보호 및 데이터 보안 문제, 규제 장벽, 천식 치료 및 기기에 대한 대중의 인식 부족 등이 있습니다.
세분화 분석
글로벌 디지털 흡입기 시장은 제품 유형, 종류, 적용 분야, 유통 채널 및 지역별로 세분화됩니다.

기기 유형 부문에서 정량식 흡입기는 시장 점유율의 약 41.2%를 차지했습니다.
정량식 흡입기는 예측 기간 동안 시장을 주도할 것으로 예상됩니다. 정량식 흡입기는 마우스피스에 맞는 가압 약물 용기를 가지고 있습니다. 대부분의 경우, 용기를 마우스피스에 밀어 넣으면 약물이 폐로 방출됩니다. 다른 유형은 흡입 시 자동으로 약물을 방출합니다. 일부 정량식 흡입기에는 남은 용량을 추적하는 카운터가 있습니다.

예를 들어, 2023년 7월, 루핀의 독일 자회사인 호르모산 파마 GmbH(Hormosan)는 성인 천식 및 만성 폐쇄성 폐질환(COPD) 치료를 위한 가압식 정량 흡입기(pMDI) 복합제인 루포벡 100/6(베클로메타손 100µg / 포모텔 6µg)을 독일에서 출시했다고 발표했습니다.
또한, 2022년 2월 8일, 약물 전달 시스템, 서비스 및 활성 물질 과학 솔루션 분야의 글로벌 리더인 압타 파마(Aptar Pharma)는 표준 정량 흡입기(pMDI)를 스마트 연결 의료 기기로 전환하는 혁신적인 디지털 호흡기 건강 솔루션인 히어로트래커 센스(HeroTracker Sense)를 출시했다고 발표했습니다.

HeroTracker Sense는 천식, COPD, 낭포성 섬유증 및 COVID-19로 인한 기타 호흡기 질환과 같은 만성 호흡기 질환으로 고통받는 전 세계 환자들의 삶의 질을 향상시키고, 약물 사용량을 추적하여 처방된 치료에 대한 순응도를 높이는 데 도움을 주기 위해 설계되었습니다.
지역 분석
북미는 2022년 시장 점유율의 약 38.4%를 차지했습니다.
북미는 활발한 연구 개발 활동과 현재 이용 가능한 첨단 호흡기 기기에 대한 인식 증가로 인해 예측 기간 동안 전체 시장 점유율의 약 38.4%를 차지할 것으로 예상됩니다. 또한 소아 및 노인 인구 모두에서 호흡기 질환 유병률의 증가가 예측 기간 동안 시장 성장을 촉진할 것입니다.
예를 들어, 2020년 9월 Teva Pharmaceuticals는 천식 환자를 위한 두 가지 디지털 유지 흡입기인 AirDuo Digihare와 ArmonAir Digihare 흡입 분말을 출시했습니다.

COVID-19 영향 분석
COVID-19는 전 세계 디지털 흡입기 시장, 특히 천식 분야에 상당한 영향을 미쳤습니다. 예를 들어, 2022년 1월에 발표된 "스코틀랜드 성인 천식 환자의 COVID-19 중증 결과 위험: 전국 코호트 연구"에 따르면 천식 환자는 천식이 없는 사람에 비해 COVID-19로 인한 입원 위험이 더 높은 것으로 나타났습니다. 따라서 COVID-19 감염 사례 증가로 호흡기 질환 환자가 늘어나면서 디지털 흡입기에 대한 수요가 증가하고 있습니다.

경쟁 환경
디지털 정량 흡입기 시장의 주요 글로벌 업체로는 Novartis International AG, Propeller Health, H&T Presspart Manufacturing Ltd, AptarGroup Inc, Amiko Digital Health Limited, Trudell Medical UK Limited, ReciPharm, Sensirion, Teva Pharmaceuticals, Cohero Health, Inc 등이 있습니다.
주요 개발 사항
 2022년 2월, AstraZeneca와 Honeywell은 호흡기 질환 치료제에 현재 사용되는 추진제보다 지구 온난화 지수가 최대 99.9% 낮은 HFO-1234ze 추진제를 사용하는 차세대 호흡기 흡입기 개발을 위해 협력했습니다.
 2020년 10월, Zydus는 만성 폐쇄성 폐질환(COPD) 환자를 위한 가압식 정량 흡입기를 출시했습니다.
보고서 구매 이유

• 기기 유형, 적용 분야, 종류, 유통 채널 및 지역별로 세분화된 글로벌 디지털 정량 흡입기 시장을 시각화하고 주요 기업 및 주요 업체를 파악하기 위해.

• 트렌드 분석 및 공동 개발을 통해 상업적 기회를 파악합니다.
• 모든 세그먼트를 포함한 디지털 흡입기 시장 수준의 다양한 데이터가 담긴 엑셀 데이터 시트를 제공합니다.

• 심층적인 질적 인터뷰와 연구를 바탕으로 종합적인 분석 결과를 담은 PDF 보고서를 제공합니다.

• 주요 업체들의 핵심 제품을 모두 포함한 제품 맵핑 자료를 엑셀 파일로 제공합니다.
글로벌 디지털 흡입기 시장 보고서는 약 69개의 표, 70개의 그림, 185페이지 분량입니다.

대상 고객 (2023년 기준)
• 제조업체/구매자
• 산업 투자자/투자 은행가
• 시장 조사 전문가
• 신흥 기업

보고서 요약(영어 원문)

Overview
Global Digital Dose Inhalers Market reached US$ YY billion in 2022 and is expected to reach US$ YY million by 2030 growing at a CAGR of YY% during the forecast period 2023-2030.
Digital dose inhalers are breathing aids that can be linked to electronic devices to check on a patient's health every day. These are especially helpful for people with respiratory diseases like asthma or obstructive diseases. Sensors in these inhalers prompt the user to take medicine at the appropriate times each day.
Digital dose inhaler health systems use electromechanical sensors and microelectronics to monitor inhaler actuation. Some gadgets include a linked smartphone, a mobile app that communicates with the patient, a cloud server, and a portal for the physician to see dashboard data.
Some digital dose inhalers can measure pollution or pollen levels or alarm patients if they forget them. Smart inhalers notify patients of missed or repeated doses and remind them to take their dosages on time, automatically, and easily.
Market Dynamics: Drivers and Restraints
Rise in prevalence of respiratory diseases
The rise in the prevalence of respiratory disease is one of the key drivers that helps the market to grow during the forecast period. Since the rise in respiratory diseases like asthma and COPD the use of digital dose inhaler devices is often used rapidly which indeed will increase the market growth.
For instance, according to the Centers for Disease Control and Prevention COPD affects an estimated 200 million people, with 3.2 million dying each year, making it the third-leading cause of mortality globally.
Asthma is one of the most common noncommunicable illnesses, impacting 262 million people worldwide. With almost 2.2 million new instances of lung cancer expected in 2022 and 1.80 million fatalities, lung cancer accounts for one in every four cancer deaths worldwide. Lower respiratory tract infection or pneumonia is a prominent cause of death, accounting for more than 2.4 million fatalities each year, primarily in low and middle-income countries (LMICs). COVID-19 has significantly increased pneumonia fatalities worldwide.
Furthermore, technological advancements in technological advancements in inhalers, Data-Driven Healthcare, the rise in the prevalence of the geriatric population, and rise in the telemedicine’s and others will further drive the market during the forecast period.
Market Dynamics: Restraint
Many restraint factors hampers the market growth during the forecast period some of the mare like, increasing medication cost and high cost associated with devices, privacy and data security concerns, regulatory hurdles, and lack of awareness among people regarding advanced treatment and devices available for asthma are going to impede the market growth.
Segment Analysis
The global digital dose inhalers is segmented based on product type, type, application, type, distribution channel and region.
The metered-dose inhaler from the device type segment accounted for approximately 41.2% of the market share
The metered-dose inhaler from the device type segment accounted for 41.2% and it is expected to be dominated during the forecast period. A metered-dose inhaler has a pressurized canister of medication that fits into a mouthpiece. In most instances, a dose of medication is released into your lungs by pushing the canister into the mouthpiece. Another type releases medication automatically when you inhale. Some metered-dose inhalers have counters that track how many doses remain.
For instance, on July 2023, Hormosan Pharma GmbH (Hormosan), Lupin’s wholly-owned subsidiary in Germany, stated that they have been launched Luforbec 100/6 (beclometasone 100µg / for motel 6µg), a fix combination in a pressurized metered dose inhaler (pMDI) for the treatment of adult asthma and chronic obstructive pulmonary disease (COPD) in Germany.
Moreover, on February 8 2022, Aptar Pharma, a global leader in drug delivery systems, services and active material science solutions, stated the launch of HeroTracker Sense, a novel digital respiratory health solution that transforms a standard metered dose inhaler (pMDI) into a smart connected healthcare device.
HeroTracker Sense is designed to help improve the lives of patients around the world suffering from chronic respiratory diseases such as asthma, COPD, Cystic Fibrosis and other respiratory conditions caused by COVID-19, to track their usage and facilitate improved adherence to their prescribed therapy.
Geographical Analysis
North America accounted for approximately 38.4% of the market share in 2022
North America is estimated to hold about 38.4% of the total market share throughout the forecast period, owing to rigorous research and development activities and increased awareness regarding the currently available hi-tech respiratory devices. In addition, an upsurge in the prevalence of respiratory conditions among both the pediatric and elderly populations will boost the market growth over the forecast years.
For instance, in September 2020, Teva Pharmaceuticals launched the AirDuo Digihare and ArmonAir Digihaler inhalation powder, two digital maintenance inhalers for patients with asthma.
COVID-19 Impact Analysis
COVID-19 had a substantial impact on the global digital dose inhalers market importantly on asthma for instance, according to the article titled "Risk of serious COVID-19 outcomes among adults with asthma in Scotland: a National Incident Cohort Study" published in January 2022 adults with asthma were found to be at an increased risk of COVID-19 hospital admission compared with those without asthma conditions. Thus, increasing cases of COVID-19 are raising the cases of respiratory disorders which generates the need for digital dose inhalers.
Competitive Landscape
The major global players in the digital dose inhalers market include Novartis International AG, Propeller Health, H&T Presspart Manufacturing Ltd, AptarGroup Inc, Amiko Digital Health Limited, Trudell Medical UK Limited, ReciPharm, Sensirion, Teva Pharmaceuticals, Cohero Health, Inc and among others
Key Developments
 In February 2022, AstraZeneca and Honeywell partnered to develop next-generation respiratory inhalers using the propellant HFO-1234ze, which has up to 99.9% less global warming potential than propellants currently used in respiratory medicines.
 In October 2020, Zydus launched a pressurised Metered Dose Inhaler for COPD patient.
Why Purchase the Report?
• To visualize the global digital dose inhalers market segmentation-based device type, application, type, distribution channel and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development
• Excel data sheet with numerous data points of digital dose inhalers market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.
The global digital dose inhalers market report would provide approximately 69 tables, 70 figures, and 185 Pages.

Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

상세 목차

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Device Type
3.2. Snippet by Application
3.3. Snippet by Type
3.4. Snippet by Distribution Channel
3.5. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Driver
4.1.1.1. Rise in the prevalence of respiratory diseases
4.1.1.2. Rise in the technology advancements
4.1.2. Restraints
4.1.2.1. Security issues
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Russia-Ukraine War Impact Analysis
5.6. DMI Opinion
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Device Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
7.1.2. Market Attractiveness Index, By Device Type
7.2. Metered Dose Inhalers *
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Dry Powder Inhalers
8. By Application
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.1.2. Market Attractiveness Index, By Application
8.2. Asthma *
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. COPD
8.4. Others
9. By Type
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
9.1.2. Market Attractiveness Index, By Type
9.2. Branded *
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Generic
10. By Distribution Channel
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
10.1.2. Market Attractiveness Index, By Distribution Channel
10.2. Hospital Pharmacies *
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Retail Pharmacies
10.4. Online Pharmacies
11. By Region
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
11.1.2. Market Attractiveness Index, By Region
11.2. North America
11.2.1. Introduction
11.2.2. Key Region-Specific Dynamics
11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.2.7.1. U.S.
11.2.7.2. Canada
11.2.7.3. Mexico
11.3. Europe
11.3.1. Introduction
11.3.2. Key Region-Specific Dynamics
11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.3.7.1. Germany
11.3.7.2. UK
11.3.7.3. France
11.3.7.4. Italy
11.3.7.5. Spain
11.3.7.6. Rest of Europe
11.4. South America
11.4.1. Introduction
11.4.2. Key Region-Specific Dynamics
11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.4.7.1. Brazil
11.4.7.2. Argentina
11.4.7.3. Rest of South America
11.5. Asia-Pacific
11.5.1. Introduction
11.5.2. Key Region-Specific Dynamics
11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.5.7.1. China
11.5.7.2. India
11.5.7.3. Japan
11.5.7.4. Australia
11.5.7.5. Rest of Asia-Pacific
11.6. Middle East and Africa
11.6.1. Introduction
11.6.2. Key Region-Specific Dynamics
11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
12. Competitive Landscape
12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis
13. Company Profiles
13.1. Novartis International AG
13.1.1. Company Overview
13.1.2. Product Portfolio and Description
13.1.3. Financial Overview
13.1.4. Key Developments
13.2. Propeller Health
13.3. H&T Presspart Manufacturing Ltd
13.4. AptarGroup Inc
13.5. Amiko Digital Health Limited
13.6. Trudell Medical UK Limited
13.7. ReciPharm
13.8. Sensirion
13.9. Teva Pharmaceuticals
13.10. Cohero Health, Inc
LIST NOT EXHAUSTIVE
14. Appendix
14.1. About Us and Services
14.2. Contact Us

언급된 주요 기업들

Novartis International AG, 4. Key Developments, Propeller Health, H&T Presspart Manufacturing Ltd, AptarGroup Inc, Amiko Digital Health Limited, Trudell Medical UK Limited, ReciPharm, Sensirion, Teva Pharmaceuticals, Cohero Health, Inc

표 목록 (Tables)

List of Tables

Table 1 Global Digital Dose Inhalers Market Value, By Device Type, 2022, 2026 & 2030 (US$ Million)

Table 2 Global Digital Dose Inhalers Market Value, By Application, 2022, 2026 & 2030 (US$ Million)

Table 3 Global Digital Dose Inhalers Market Value, By Type, 2022, 2026 & 2030 (US$ Million)

Table 4 Global Digital Dose Inhalers Market Value, By Distribution Channel, 2022, 2026 & 2030 (US$ Million)

Table 5 Global Digital Dose Inhalers Market Value, By Region, 2022, 2026 & 2030 (US$ Million)

Table 6 Global Digital Dose Inhalers Market Value, By Device Type, 2022, 2026 & 2030 (US$ Million)

Table 7 Global Digital Dose Inhalers Market Value, By Device Type, 2021-2030 (US$ Million)

Table 8 Global Digital Dose Inhalers Market Value, By Application, 2022, 2026 & 2030 (US$ Million)

Table 9 Global Digital Dose Inhalers Market Value, By Application, 2021-2030 (US$ Million)

Table 10 Global Digital Dose Inhalers Market Value, By Type, 2022, 2026 & 2030 (US$ Million)

Table 11 Global Digital Dose Inhalers Market Value, By Type, 2021-2030 (US$ Million)

Table 12 Global Digital Dose Inhalers Market Value, By Distribution Channel, 2022, 2026 & 2030 (US$ Million)

Table 13 Global Digital Dose Inhalers Market Value, By Distribution Channel, 2021-2030 (US$ Million)

Table 14 Global Digital Dose Inhalers Market Value, By Region, 2022, 2026 & 2030 (US$ Million)

Table 15 Global Digital Dose Inhalers Market Value, By Region, 2021-2030 (US$ Million)

Table 16 North America Digital Dose Inhalers Market Value, By Device Type, 2021-2030 (US$ Million)

Table 17 North America Digital Dose Inhalers Market Value, By Application, 2021-2030 (US$ Million)

Table 18 North America Digital Dose Inhalers Market Value, By Type, 2021-2030 (US$ Million)

Table 19 North America Digital Dose Inhalers Market Value, By Distribution Channel, 2021-2030 (US$ Million)

Table 20 North America Digital Dose Inhalers Market Value, By Country, 2021-2030 (US$ Million)

Table 21 South America Digital Dose Inhalers Market Value, By Device Type, 2021-2030 (US$ Million)

Table 22 South America Digital Dose Inhalers Market Value, By Application, 2021-2030 (US$ Million)

Table 23 South America Digital Dose Inhalers Market Value, By Type, 2021-2030 (US$ Million)

Table 24 South America Digital Dose Inhalers Market Value, By Distribution Channel, 2021-2030 (US$ Million)

Table 25 South America Digital Dose Inhalers Market Value, By Country, 2021-2030 (US$ Million)

Table 26 Europe Digital Dose Inhalers Market Value, By Device Type, 2021-2030 (US$ Million)

Table 27 Europe Digital Dose Inhalers Market Value, By Application, 2021-2030 (US$ Million)

Table 28 Europe Digital Dose Inhalers Market Value, By Type, 2021-2030 (US$ Million)

Table 29 Europe Digital Dose Inhalers Market Value, By Distribution Channel, 2021-2030 (US$ Million)

Table 30 Europe Digital Dose Inhalers Market Value, By Country, 2021-2030 (US$ Million)

Table 31 Asia-Pacific Digital Dose Inhalers Market Value, By Device Type, 2021-2030 (US$ Million)

Table 32 Asia-Pacific Digital Dose Inhalers Market Value, By Application, 2021-2030 (US$ Million)

Table 33 Asia-Pacific Digital Dose Inhalers Market Value, By Type, 2021-2030 (US$ Million)

Table 34 Asia-Pacific Digital Dose Inhalers Market Value, By Distribution Channel, 2021-2030 (US$ Million)

Table 35 Asia-Pacific Digital Dose Inhalers Market Value, By Country, 2021-2030 (US$ Million)

Table 36 Middle East & Africa Digital Dose Inhalers Market Value, By Device Type, 2021-2030 (US$ Million)

Table 37 Middle East & Africa Digital Dose Inhalers Market Value, By Application, 2021-2030 (US$ Million)

Table 38 Middle East & Africa Digital Dose Inhalers Market Value, By Type, 2021-2030 (US$ Million)

Table 39 Middle East & Africa Digital Dose Inhalers Market Value, By Distribution Channel, 2021-2030 (US$ Million)

Table 40 Novartis International AG: Overview

Table 41 Novartis International AG: Product Portfolio

Table 42 Novartis International AG: Key Developments

Table 43 Propeller Health: Overview

Table 44 Propeller Health: Product Portfolio

Table 45 Propeller Health: Key Developments

Table 46 H&T Presspart Manufacturing Ltd: Overview

Table 47 H&T Presspart Manufacturing Ltd: Product Portfolio

Table 48 H&T Presspart Manufacturing Ltd: Key Developments

Table 49 AptarGroup Inc: Overview

Table 50 AptarGroup Inc: Product Portfolio

Table 51 AptarGroup Inc: Key Developments

Table 52 Amiko Digital Health Limited: Overview

Table 53 Amiko Digital Health Limited: Product Portfolio

Table 54 Amiko Digital Health Limited: Key Developments

Table 55 Trudell Medical UK Limited: Overview

Table 56 Trudell Medical UK Limited: Product Portfolio

Table 57 Trudell Medical UK Limited: Key Developments

Table 58 ReciPharm: Overview

Table 59 ReciPharm: Product Portfolio

Table 60 ReciPharm: Key Developments

Table 61 Sensirion: Overview

Table 62 Sensirion: Product Portfolio

Table 63 Sensirion: Key Developments

Table 64 Teva Pharmaceuticals: Overview

Table 65 Teva Pharmaceuticals: Product Portfolio

Table 66 Teva Pharmaceuticals: Key Developments

Table 67 Cohero Health, Inc: Overview

Table 68 Cohero Health, Inc: Product Portfolio

Table 69 Cohero Health, Inc: Key Developments

그림 목록 (Figures)

List of Figures

Figure 1 Global Digital Dose Inhalers Market Value, 2021-2030 (US$ Million)

Figure 2 Global Digital Dose Inhalers Market Share, By Device Type, 2022 & 2030 (%)

Figure 3 Global Digital Dose Inhalers Market Share, By Application, 2022 & 2030 (%)

Figure 4 Global Digital Dose Inhalers Market Share, By Type, 2022 & 2030 (%)

Figure 5 Global Digital Dose Inhalers Market Share, By Distribution Channel, 2022 & 2030 (%)

Figure 6 Global Digital Dose Inhalers Market Share, By Region, 2022 & 2030 (%)

Figure 7 Global Digital Dose Inhalers Market Y-o-Y Growth, By Device Type, 2022-2030 (%)

Figure 8 Metered Dose Inhalers Digital Dose Inhalers Market Value, 2021-2030 (US$ Million)

Figure 9 Dry Powder Inhalers Digital Dose Inhalers Market Value, 2021-2030 (US$ Million)

Figure 10 Global Digital Dose Inhalers Market Y-o-Y Growth, By Application, 2022-2030 (%)

Figure 11 Asthma Application in Global Digital Dose Inhalers Market Value, 2021-2030 (US$ Million)

Figure 12 COPD Application in Global Digital Dose Inhalers Market Value, 2021-2030 (US$ Million)

Figure 13 Others Application in Global Digital Dose Inhalers Market Value, 2021-2030 (US$ Million)

Figure 14 Global Digital Dose Inhalers Market Y-o-Y Growth, By Type, 2022-2030 (%)

Figure 15 Branded Type in Global Digital Dose Inhalers Market Value, 2021-2030 (US$ Million)

Figure 16 Generic Type in Global Digital Dose Inhalers Market Value, 2021-2030 (US$ Million)

Figure 17 Global Digital Dose Inhalers Market Y-o-Y Growth, By Distribution Channel, 2022-2030 (%)

Figure 18 Hospital Pharmacies Distribution Channel in Global Digital Dose Inhalers Market Value, 2021-2030 (US$ Million)

Figure 19 Retail Pharmacies Distribution Channel in Global Digital Dose Inhalers Market Value, 2021-2030 (US$ Million)

Figure 20 Online Pharmacies Distribution Channel in Global Digital Dose Inhalers Market Value, 2021-2030 (US$ Million)

Figure 21 Global Digital Dose Inhalers Market Y-o-Y Growth, By Region, 2022-2030 (%)

Figure 22 North America Digital Dose Inhalers Market Value, 2021-2030 (US$ Million)

Figure 23 Asia-Pacific Digital Dose Inhalers Market Value, 2021-2030 (US$ Million)

Figure 24 Europe Digital Dose Inhalers Market Value, 2021-2030 (US$ Million)

Figure 25 South America Digital Dose Inhalers Market Value, 2021-2030 (US$ Million)

Figure 26 Middle East and Africa Digital Dose Inhalers Market Value, 2021-2030 (US$ Million)

Figure 27 North America Digital Dose Inhalers Market Value, 2021-2030 (US$ Million)

Figure 28 North America Digital Dose Inhalers Market Share, By Device Type, 2022 & 2030 (%)

Figure 29 North America Digital Dose Inhalers Market Share, By Application, 2022 & 2030 (%)

Figure 30 North America Digital Dose Inhalers Market Share, By Type, 2022 & 2030 (%)

Figure 31 North America Digital Dose Inhalers Market Share, By Distribution Channel, 2022 & 2030 (%)

Figure 32 North America Digital Dose Inhalers Market Share, By Country, 2022 & 2030 (%)

Figure 33 South America Digital Dose Inhalers Market Value, 2021-2030 (US$ Million)

Figure 34 South America Digital Dose Inhalers Market Share, By Device Type, 2022 & 2030 (%)

Figure 35 South America Digital Dose Inhalers Market Share, By Application, 2022 & 2030 (%)

Figure 36 South America Digital Dose Inhalers Market Share, By Type, 2022 & 2030 (%)

Figure 37 South America Digital Dose Inhalers Market Share, By Distribution Channel, 2022 & 2030 (%)

Figure 38 South America Digital Dose Inhalers Market Share, By Country, 2022 & 2030 (%)

Figure 39 Europe Digital Dose Inhalers Market Value, 2021-2030 (US$ Million)

Figure 40 Europe Digital Dose Inhalers Market Share, By Device Type, 2022 & 2030 (%)

Figure 41 Europe Digital Dose Inhalers Market Share, By Application, 2022 & 2030 (%)

Figure 42 Europe Digital Dose Inhalers Market Share, By Type, 2022 & 2030 (%)

Figure 43 Europe Digital Dose Inhalers Market Share, By Distribution Channel, 2022 & 2030 (%)

Figure 44 Europe Digital Dose Inhalers Market Share, By Country, 2022 & 2030 (%)

Figure 45 Asia-Pacific Digital Dose Inhalers Market Value, 2021-2030 (US$ Million)

Figure 46 Asia-Pacific Digital Dose Inhalers Market Share, By Device Type, 2022 & 2030 (%)

Figure 47 Asia-Pacific Digital Dose Inhalers Market Share, By Application, 2022 & 2030 (%)

Figure 48 Asia-Pacific Digital Dose Inhalers Market Share, By Type, 2022 & 2030 (%)

Figure 49 Asia-Pacific Digital Dose Inhalers Market Share, By Distribution Channel, 2022 & 2030 (%)

Figure 50 Asia-Pacific Digital Dose Inhalers Market Share, By Country, 2022 & 2030 (%)

Figure 51 Middle East & Africa Digital Dose Inhalers Market Value, 2021-2030 (US$ Million)

Figure 52 Middle East & Africa Digital Dose Inhalers Market Share, By Device Type, 2022 & 2030 (%)

Figure 53 Middle East & Africa Digital Dose Inhalers Market Share, By Application, 2022 & 2030 (%)

Figure 54 Middle East & Africa Digital Dose Inhalers Market Share, By Type, 2022 & 2030 (%)

Figure 55 Middle East & Africa Digital Dose Inhalers Market Share, By Distribution Channel, 2022 & 2030 (%)

Figure 56 Novartis International AG: Financials

Figure 57 Propeller Health: Financials

Figure 58 H&T Presspart Manufacturing Ltd: Financials

Figure 59 AptarGroup Inc: Financials

Figure 60 Amiko Digital Health Limited: Financials

Figure 61 Trudell Medical UK Limited: Financials

Figure 62 ReciPharm: Financials

Figure 63 Sensirion: Financials

Figure 64 Teva Pharmaceuticals: Financials

Figure 65 Cohero Health, Inc: Financials

글로벌 디지털 흡입기 시장 – 2023-2030

Global Digital Dose Inhalers Market -2023-2030